183 related articles for article (PubMed ID: 21513988)
1. Placental-specific microRNA in maternal circulation--identification of appropriate pregnancy-associated microRNAs with diagnostic potential.
Kotlabova K; Doucha J; Hromadnikova I
J Reprod Immunol; 2011 May; 89(2):185-91. PubMed ID: 21513988
[TBL] [Abstract][Full Text] [Related]
2. [Detection of placenta-specific microRNAs in maternal circulation].
Hromadníková I; Kotlabová K; Jirásek JE; Doucha J
Ceska Gynekol; 2010 May; 75(3):252-6. PubMed ID: 20731307
[TBL] [Abstract][Full Text] [Related]
3. Expression profile of C19MC microRNAs in placental tissue in pregnancy-related complications.
Hromadnikova I; Kotlabova K; Ondrackova M; Pirkova P; Kestlerova A; Novotna V; Hympanova L; Krofta L
DNA Cell Biol; 2015 Jun; 34(6):437-57. PubMed ID: 25825993
[TBL] [Abstract][Full Text] [Related]
4. Absolute and relative quantification of placenta-specific micrornas in maternal circulation with placental insufficiency-related complications.
Hromadnikova I; Kotlabova K; Doucha J; Dlouha K; Krofta L
J Mol Diagn; 2012; 14(2):160-7. PubMed ID: 22251611
[TBL] [Abstract][Full Text] [Related]
5. Characterization of placenta-specific microRNAs in fetal growth restriction pregnancy.
Higashijima A; Miura K; Mishima H; Kinoshita A; Jo O; Abe S; Hasegawa Y; Miura S; Yamasaki K; Yoshida A; Yoshiura K; Masuzaki H
Prenat Diagn; 2013 Mar; 33(3):214-22. PubMed ID: 23354729
[TBL] [Abstract][Full Text] [Related]
6. First trimester screening of circulating C19MC microRNAs can predict subsequent onset of gestational hypertension.
Hromadnikova I; Kotlabova K; Hympanova L; Doucha J; Krofta L
PLoS One; 2014; 9(12):e113735. PubMed ID: 25502889
[TBL] [Abstract][Full Text] [Related]
7. Follow-up of gestational trophoblastic disease/neoplasia via quantification of circulating nucleic acids of placental origin using C19MC microRNAs, hypermethylated RASSF1A, and SRY sequences.
Hromadnikova I; Kotlabova K; Krofta L; Hron F
Tumour Biol; 2017 Apr; 39(4):1010428317697548. PubMed ID: 28381180
[TBL] [Abstract][Full Text] [Related]
8. The Prediction of Gestational Hypertension, Preeclampsia and Fetal Growth Restriction via the First Trimester Screening of Plasma Exosomal C19MC microRNAs.
Hromadnikova I; Dvorakova L; Kotlabova K; Krofta L
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31216670
[TBL] [Abstract][Full Text] [Related]
9. First trimester screening of circulating C19MC microRNAs and the evaluation of their potential to predict the onset of preeclampsia and IUGR.
Hromadnikova I; Kotlabova K; Ivankova K; Krofta L
PLoS One; 2017; 12(2):e0171756. PubMed ID: 28182660
[TBL] [Abstract][Full Text] [Related]
10. Circulating levels of maternal plasma cell-free pregnancy-associated placenta-specific microRNAs are associated with placental weight.
Miura K; Morisaki S; Abe S; Higashijima A; Hasegawa Y; Miura S; Tateishi S; Mishima H; Yoshiura K; Masuzaki H
Placenta; 2014 Oct; 35(10):848-51. PubMed ID: 25015175
[TBL] [Abstract][Full Text] [Related]
11. Circulating chromosome 19 miRNA cluster microRNAs in pregnant women with severe pre-eclampsia.
Miura K; Higashijima A; Murakami Y; Tsukamoto O; Hasegawa Y; Abe S; Fuchi N; Miura S; Kaneuchi M; Masuzaki H
J Obstet Gynaecol Res; 2015 Oct; 41(10):1526-32. PubMed ID: 26224638
[TBL] [Abstract][Full Text] [Related]
12. Detection and characterization of placental microRNAs in maternal plasma.
Chim SS; Shing TK; Hung EC; Leung TY; Lau TK; Chiu RW; Lo YM
Clin Chem; 2008 Mar; 54(3):482-90. PubMed ID: 18218722
[TBL] [Abstract][Full Text] [Related]
13. Increased Levels of Cell-Free miR-517a and Decreased Levels of Cell-Free miR-518b in Maternal Plasma Samples From Placenta Previa Pregnancies at 32 Weeks of Gestation.
Hasegawa Y; Miura K; Higashijima A; Abe S; Miura S; Yoshiura K; Masuzaki H
Reprod Sci; 2015 Dec; 22(12):1569-76. PubMed ID: 26040940
[TBL] [Abstract][Full Text] [Related]
14. Identification of potential early biomarkers of preeclampsia.
Timofeeva AV; Gusar VA; Kan NE; Prozorovskaya KN; Karapetyan AO; Bayev OR; Chagovets VV; Kliver SF; Iakovishina DY; Frankevich VE; Sukhikh GT
Placenta; 2018 Jan; 61():61-71. PubMed ID: 29277273
[TBL] [Abstract][Full Text] [Related]
15. Identification of pregnancy-associated microRNAs in maternal plasma.
Miura K; Miura S; Yamasaki K; Higashijima A; Kinoshita A; Yoshiura K; Masuzaki H
Clin Chem; 2010 Nov; 56(11):1767-71. PubMed ID: 20729298
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of microRNAs in porcine placentas on days 30 and 90 of gestation.
Su L; Zhao S; Zhu M; Yu M
Reprod Fertil Dev; 2010; 22(8):1175-82. PubMed ID: 20883642
[TBL] [Abstract][Full Text] [Related]
17. Altered Expression of miR-518b and miR-519a in the placenta is associated with low fetal birth weight.
Wang D; Na Q; Song WW; Song GY
Am J Perinatol; 2014 Oct; 31(9):729-34. PubMed ID: 24683074
[TBL] [Abstract][Full Text] [Related]
18. Circulating C19MC microRNAs in preeclampsia, gestational hypertension, and fetal growth restriction.
Hromadnikova I; Kotlabova K; Ondrackova M; Kestlerova A; Novotna V; Hympanova L; Doucha J; Krofta L
Mediators Inflamm; 2013; 2013():186041. PubMed ID: 24347821
[TBL] [Abstract][Full Text] [Related]
19. Effect of labor on plasma concentrations and postpartum clearance of cell-free, pregnancy-associated, placenta-specific microRNAs.
Morisaki S; Miura K; Higashijima A; Abe S; Miura S; Hasegawa Y; Yoshida A; Kaneuchi M; Yoshiura K; Masuzaki H
Prenat Diagn; 2015 Jan; 35(1):44-50. PubMed ID: 25125329
[TBL] [Abstract][Full Text] [Related]
20. Reference values for circulating pregnancy-associated microRNAs in maternal plasma and their clinical usefulness in uncomplicated pregnancy and hypertensive disorder of pregnancy.
Murakami Y; Miura K; Sato S; Higashijima A; Hasegawa Y; Miura S; Yoshiura KI; Masuzaki H
J Obstet Gynaecol Res; 2018 May; 44(5):840-851. PubMed ID: 29516574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
